Related Experiment Videos
[Neutropenic enteropathy associated with multiple myeloma]
A Gamboa-Domínguez1, J L Velázquez-Ceceña, E Reyes-Gutiérrez
1Departamento de Patología, Instituto Nacional de Nutrición Salvador Zubirán, México, D.F.
Revista De Gastroenterologia De Mexico
|April 1, 1995
Summary
Neutropenic enteropathy (NE), a severe intestinal condition, is rarely associated with multiple myeloma (MM). This case report details the third known instance of NE in an MM patient, highlighting its aggressive nature.
Area of Science:
- Gastroenterology
- Hematology
- Oncology
Background:
- Neutropenic enteropathy (NE) is an acute intestinal condition often linked to chemotherapy in pediatric leukemias and lymphomas.
- Less common causes include neutropenia in adults due to autoimmune diseases, aplastic anemia, cyclic neutropenia, or solid tumors.
- Multiple myeloma (MM) is an uncommon but serious association with NE.
Observation:
- A 62-year-old male with a history of MM diagnosed 10 months prior, undergoing chemotherapy, presented with severe abdominal pain, nausea, vomiting, diarrhea, and rectal bleeding.
- Autopsy revealed extensive colonic ulcers and thickening (40% surface area) and ileal involvement (5%).
- Microscopic examination showed ischemic necrosis of the mucosa and submucosa with bacterial invasion and a lack of acute inflammatory response.
Findings:
- This case represents the third documented instance of NE associated with MM.
- The patient had received vincristine and steroids shortly before developing neutropenia, consistent with previous reports.
- This report provides clinical and morphological details of NE in an MM patient, being the first illustrated case from Mexico.
Implications:
- This case underscores the aggressive clinical behavior of NE, even in the context of multiple myeloma.
- It highlights the importance of considering NE in neutropenic patients with gastrointestinal symptoms, particularly those with hematological malignancies.
- Further research into the specific mechanisms and management of NE in MM patients is warranted.